help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lacasa, D.
Right arrow Articles by Giudicelli, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lacasa, D.
Right arrow Articles by Giudicelli, Y.
Endocrinology Vol. 138, No. 8 3181-3186
Copyright © 1997 by The Endocrine Society


ARTICLES

Site-Related Specificities of the Control by Androgenic Status of Adipogenesis and Mitogen-Activated Protein Kinase Cascade/c-fos Signaling Pathways in Rat Preadipocytes1

D. Lacasa, E. Garcia, D. Henriot, B. Agli and Y. Giudicelli

Service de Biochimie, INSERM CJF 94–02, Faculté de Médecine Paris-Ouest, Université René Descartes (Paris V) and Centre Hospitalier de Poissy 78 303 Cédex, France

Address all correspondence and requests for reprints to: D. Lacasa, Centre Hospitalier, Service de Biochimie Medicale, 10, rue du Champ-Gaillard, Poissy Cedex, 78303 France.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In rats, castration induces a complete defective adipose conversion of preadipocytes from the epididymal fat depots (Lacasa, D., B. Agli, D. Noynarol, and Y. Giudicelli, 1995, Endocrine 3: 789–793). The aim of this study was to establish the eventual site-specificity of this effect as well as the mechanisms involved.

Therefore, the influence of androgenic status on the Fos protein induction and the Raf/mitogen-activated protein (MAP) kinase kinase (MEK)/MAP cascade, which are all required for adipose conversion of preadipocytes, was compared in proliferating and differentiated preadipocytes from femoral sc and deep intraabdominal (epididymal and perirenal) fat depots.

In epididymal and perirenal proliferating preadipocytes, increased proliferation due to castration is associated with increased MAP kinase activity. However, higher immunoreactive levels of the upstream activators of MAP kinase, Raf-1 and MEK, were observed only in epididymal cells. Moreover, in vivo testosterone treatment corrected the effects of castration on Raf-1 but not on MEK and MAP kinase.

MAP kinase activity was decreased during the course of adipogenesis. In differentiated cells, MAP kinase activity showed variations according to the anatomical origin of preadipocytes but not to the androgenic status. In contrast, MEK and Raf-1 immunoreactive levels were both sensitive to androgenic status but were differently affected depending on cell origin. Finally, the defective adipogenesis seen in epididymal preadipocytes from castrated rats was associated with reduced Fos protein induction in these cells, an alteration which was partly corrected by testosterone-treatment.

Taken together, these results suggest that androgenic status affects adipogenesis from deep intraabdominal preadipocytes through alterations of some components of the MAP kinase cascade/Fos signaling pathways.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
IT SEEMS now clear that fat distribution and accumulation are under the control of sex steroid hormones. Android obesity, which is an important risk factor for cardiovascular diseases, is characterized by excessive adipose tissue deposition in abdominal and visceral regions (1).

The molecular basis of the regulation of adipose tissue distribution by sex hormones is still poorly understood. Direct effects of androgens on adipose tissue are suggested by the presence of androgen receptors in precursor and mature fat cells (2, 3).

Increased adipogenesis (preadipocyte proliferation and differentiation) is one important mechanism contributing to the development of obesity. The influence of both the anatomical origin (4, 5) and the hormonal status (6) on adipogenesis can be studied in vitro by means of primary culture of preadipocytes. By using this experimental approach, we have recently shown that castration exerts site-specific effects on adipogenesis. Namely, an increased proliferation capacity and a loss of differentiation capacity were observed in epididymal preadipocytes from castrated rats (7). In contrast, adipose conversion of preadipocytes from sc territories was insensitive to castration (7).

The mitogen-activated protein kinase (MAP kinase) cascade is activated by growth factors such as EGF and insulin and plays a crucial role in cell proliferation and differentiation (for a review, see 8 . Two isoforms of MAP kinase (p42 and p44 MAP kinases) are activated by phosphorylation of their tyrosine 185 and threonine 183 residues by MAP kinase kinases (MEKs). MEKs are themselves activated by several kinases such as Raf-1 (9).

MAP kinase activation by growth factors results in phosphorylation of transcriptional factors which in turn, induces a rapid increase in c-fos expression (10). This proto-oncogene plays a pivotal role in the control of preadipocyte proliferation and differentiation (11).

Altered MAP kinase cascade/Fos protein signaling pathways can thus be considered as one possible mechanism explaining the increased proliferation and defective differentiation capacities of rat epididymal preadipocytes after castration. This hypothesis was presently tested by comparing the effects of the androgenic status on Raf/MEK/MAP kinase and Fos protein induction in confluent and differentiated preadipocytes from rat sc, epididymal, and perirenal fat depots.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Materials
DMEM, DMEM-Ham’s F12 (50:50 mix), FBS and antiserum and synthetic peptide specific for {zeta} PKC were obtained from Life Technologies (Grand Island, NY). The antisera and synthetic peptides specific for Raf-1 (C12) and MEK1 (C18) were from Santa-Cruz Biotechnology (Santa-Cruz, CA). The antibody and synthetic peptide specific for c-fos (OP17) were from Oncogene Science (Cambridge, MA). Western blotting protocols and p42/p44 MAP kinase enzyme assay system were from the Radiochemical Centre (Amersham, Buckinghamshire, UK). Prestained molecular weight markers were from Sigma Chemical Co. (St. Louis, MO). Testosterone RIA tests were provided by Biomérieux (Marcy l’Étoile, France). All other chemicals were of reagent grade.

Methods
Animals.
Procedures with experimental animals are authorized and follow the guidelines of the Ministère of Agriculture (France) (authorization 006614). Male Sprague-Dawley rats (125–150 g) were castrated under pentobarbital anesthesia (40 mg/kg ip) and treated as previously described (7, 12). Briefly, 5 days after the operation, half of the castrated rats received one sc injection of testosterone propionate (0.5 mg/100 g BW) every other day for 10 days (CAST + T) while the other half (CAST) and the sham-operated rats (SHAM) received the vehicle (polyethylene glycol) only. One day after the last injection, rats were killed by decapitation. Serum testosterone levels were measured as described in (7) and were on the day of sacrifice: 1.5 ± 0.2, less than 0.1 and 13.5 ± 3.7 nmol/liter in SHAM, CAST and CAST + T rats. The characteristics of the adipose tissues of the different experimental groups were given in (12).

Cell culture
Cell preparation and culture were performed as described in Ref. 13. Briefly, preadipocytes obtained from the stroma-vascular fraction of adipose tissue by collagenase digestion were plated at a density of 1–2 104 cells/cm2 in cell culture dishes. After 12 h, cells were washed and fed with DMEM-8% FBS. Medium was changed every other day. At confluence, (2–3 days postplating), cells were harvested or allowed to differentiate in DMEM-Ham’s F12 medium (50:50) containing 5 µg/ml insulin, 10 µg/ml transferrin, and 200 pM T3 (ITT medium) (13). Whatever the anatomical origin, 80% at least of the cultured control cells were fully differentiated at day 8–10 postconfluence.

Cellular extract preparation
Preadipocyte cytosolic and membrane fractions were prepared as described in (12). For c-fos assay, preadipocytes were serum-starved for 18 h and then exposed to 10% serum for 90 min. Then, cells were scraped and sonicated in cold buffer containing 50 mM Tris, pH 8.0, 120 mM NaCl, 1% NP40, 0.5% deoxycholate, 0.1% SDS, 0.5 mM phenylmethylsulfonyl fluoride, 25 µg/ml aprotinin and 20 µg/ml leupeptin. After centrifugation at 100,000 x g for 15 min at 4 C, the resulting supernatant was denaturated with Laemmli buffer and stored at -20 C.

Western blot analysis
Equal amounts (10–50 µg) of cellular fractions and prestained molecular weight markers were subjected to SDS-PAGE (10–12.5%). Proteins were transferred to polyvinylidenedifluoride membranes. The filters were subsequently stained to verify equal protein loading and transfer. After blocking with TBS containing 1% Tween-20 (TTBS) and 2.5% gelatin for 2 h, membranes were incubated overnight with the antibodies diluted in TTBS-2.5% gelatin (anti-Raf-1, anti-c-fos and anti-{zeta} PKC at 0.5 µg/ml and anti-MEK at 0.1 µg/ml). Membranes were washed and incubated with the secondary antiserum coupled to horse radish peroxydase (1:2000 dilution in TTBS). Membranes were extensively washed, incubated with the ECL detection solution and then exposed to x-ray films. Signals were quantified by densitometry. Reprobing of the membranes gave identical results. Specificity of the immunoreactive proteins was verified by loss of the immunoreactivity of samples when incubated with the antiserum neutralized by the corresponding specific peptide. Bands presented in the figures are the only ones visible on the films. Control experiments with various amounts of protein (10–75 µg) were performed to ensure that the densitometric signal intensity was proportional to the loaded amount of protein.

MAP kinase assay
Proliferating and differentiated preadipocytes were scraped and sonicated in cold buffer containing 10 mM Tris, pH 7.4, 150 mM NaCl, 2 mM EGTA, 2 mM DTT, 1 mM sodium orthovanadate, 30 mM ß-glycerophosphate, 1 mM phenylmethylsulfonyl fluoride, 20 µg/ml leupeptin, and 25 µg/ml aprotinin. After centrifugation at 100,000 x g for 30 min at 4 C, cytosolic extracts were kept at -80 C. MAP kinase activity was measured in the extracts using p42/p44 MAP kinase enzyme assay system as described in Ref. 14.

Cell counting
Perirenal preadipocytes from SHAM, CAST, and CAST + T rats were isolated and seeded at 1 105 cells per well. Cell number was determined at days 1, 2, 3, and 4 postplating. Cells were trypsinized and counted in a hemocytometer. Cell viability experiments showed that, whatever the animal treatments, about 95% of the cells excluded trypan blue after three washings.

Glycerol 3-phosphate deshydrogenase (GPDH) assay
Cell differentiation was followed by measuring the GPDH activity according to Wise and Green (15).

Other determinations
Protein concentration and lactate dehydrogenase activity were assessed as previously described (7). All results are expressed as means ± SEM from at least four individual experiments. Comparison between groups were made using ANOVA with Bonferroni P values.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Perirenal preadipocyte growth and differentiation
Data in Fig. 1Go compare the influence of rat androgenic status on the in vitro proliferation and differentiation capacities of preadipocytes from the perirenal fat depots. As can be seen, castration increased the number of cells at day 4 by about 70% (P < 0.05) (mean of four separate experiments). This effect was not corrected by testosterone treatment. Moreover, castration increased by a factor of 2 the GPDH activity, a late marker of adipogenesis (15). LDH activity which remained stable throughout the differentiation process was unaffected by the androgenic status. Thus perirenal preadipocytes differ from epididymal preadipocytes where the differentiation process is completely inhibited after castration (7).



View larger version (15K):
[in this window]
[in a new window]
 
Figure 1. Influence of androgenic status on growth curve and differentiation level of preadipocytes from perirenal fat depots. A, Perirenal preadipocytes from SHAM ({blacksquare}), CAST ({square}) and CAST + T ({triangleup}) rats were prepared and plated in DMEM-8%FBS. At the indicated days, cells were counted. Data from one representative experiment repeated four times are presented. Each experiment was performed in duplicate. P < 0.05 comparison between preadipocytes from CAST and SHAM rats using the one-way ANOVA. B, Perirenal preadipocytes from SHAM, CAST, and CAST + T rats were allowed to differentiate in ITT medium. After 8–10 days, GPDH and LDH activities were measured in cytosolic fractions. Data are means ± SEM of 10–12 separate experiments performed in duplicate. *, P < 0.01 comparison between preadipocytes from CAST and SHAM rats using the one-way ANOVA

 
MAP kinase cascade
To explain these site-related discrepancies, the influence of androgenic status on some components of the MAP kinase cascade was studied in preadipocytes from different intraabdominal fat depots and from the SC adipose tissue.

p42/p44 MAP kinase activity
First, p42/p44 MAP kinase activity was measured in cytosolic extracts of confluent and differentiated cells.

As shown in Table 1Go, the MAP kinase activities found in proliferating preadipocytes from the control groups were identical whatever their anatomical origin. In contrast, castration induced a significant increase in the MAP kinase activity of proliferating preadipocytes from the two deep intraabdominal fat depots but not from the sc region. In vivo treatment by testosterone failed, however, to reverse these effects of castration.


View this table:
[in this window]
[in a new window]
 
Table 1. Influence of androgenic status on p42/p44 MAP kinase of proliferating and differentiated preadipocytes from femoral SC, epididymal and perirenal fat depots

 
In differentiated cells, MAP kinase activity was systematically lower (about 5-fold) than in proliferating cells whatever their anatomical origin and the androgenic status. It also should be noted that MAP kinase activities were significantly lower in perirenal than in sc and epididymal cells, a difference which was not observed in proliferating cells. Moreover, MAP kinase activity was not modified by the androgenic status whatever the anatomical origin of the differentiated cells.

Immunoreactive MEK status
As shown in Fig. 2Go, the amount of MEK (determined by Western blot) in preadipocyte cytosolic fractions was sensitive to castration only in epididymal preadipocytes where it increased by 150 ± 3% (P < 0.05) at confluence and by 125 ± 24% (P < 0.05) at differentiation. In these cells, however, in vivo testosterone treatment failed to restore to normal MEK amount. In contrast, MEK amounts were not significantly modified by the androgenic status in sc and perirenal pre-adipocytes whatever their stage of culture.



View larger version (37K):
[in this window]
[in a new window]
 
Figure 2. Influence of androgenic status on immunoreactive MEK in confluent and differentiated preadipocytes. Cytosolic fractions of confluent and differentiated preadipocytes from femoral SC, epididymal and perirenal fat depots of SHAM (A, D, and G), CAST (B, E, and H) and CAST + T (C, F, and I) rats were probed with anti MEK antibody. A, Representative Western blot analysis of MEK protein. B, Densitometric analysis of MEK Western blots. The data are the means ± SEM obtained from six separate experiments and are expressed as percentage of control values (100% is assigned to each type of pre-adipocytes from SHAM rats). *, P < 0.05. Prestained molecular weight markers shown are 57 kDa and 39.5 kDa.

 
Immunoreactive Raf-1 status
Raf-1 protein status, one of the upstream activators of MEK (9), was studied in preadipocyte cytosolic extracts. The antibody specific for Raf-1 detected several bands. Their immunospecificity was confirmed because when Raf-1 antibody was neutralized by the corresponding immunogenic Raf-1 peptide, none of these bands could be detected. These bands also observed in other cell types have been shown to represent various Raf-1 phosphorylation states (16).

At confluence, cytosolic amount of Raf-1 was increased by castration in preadipocytes from epididymal (+ 75 ± 30%, P < 0.05) but not from the other fat depots. In contrast, in differentiated preadipocytes, castration increased Raf-1 amount only in perirenal (+ 70 ± 30%, P < 0.05) and sc (+150 ± 40%, P < 0.05) cells and testosterone treatment failed to correct these alterations (Fig. 3Go).



View larger version (40K):
[in this window]
[in a new window]
 
Figure 3. Influence of androgenic status on immunoreactive Raf-1 in confluent and differentiated preadipocytes. Cytosolic fractions from confluent and differentiated preadipocytes from femoral SC, epididymal and perirenal fat depots of SHAM (A, D, and G), CAST (B, E, and H) and CAST + T (C, F, and I) rats were probed with anti Raf-1 antibody. A, Representative Western blot analysis of Raf-1 protein. B, Densitometric analysis of Raf-1 Western blots. The data are the means ± SEM obtained from six separate experiments and are expressed as percentage of control values (100% is assigned to each type of preadipocytes from SHAM rats). *, P < 0.05. Prestained molecular weight markers shown are 86 kDa and 70 kDa.

 
In preadipocyte membrane fraction, where Raf-1 activation is thought to mainly occur (16), variations in the androgenic status led to the same results as those described above in cytosol, even though the Raf-1 amount was lower in membrane fractions (data not shown).

{zeta}-PKC status
Finally, {zeta}PKC status was also examined as this isoform was recently shown to activate the MEK/MAP kinase cascade (17). {zeta}-PKC cytosolic amount was unmodified by the androgenic status whatever the anatomical origin of the preadipocytes and their stage of culture (data not shown). These data indicate that the androgenic status affects specifically some but not all components of the MAP kinase signaling pathway.

Fos protein induction
Induction of the proto-oncogene c-fos by serum was studied by following the expression of immunoreactive Fos protein in confluent and differentiated preadipocytes.

A Fos immunoreactive protein of about 50 kDa was detected in all experimental groups after 1–2 h serum induction. Data presented in Fig. 4Go show that in confluent pre-adipocytes, Fos protein induction was not significantly altered by the androgenic status whatever the anatomical origin of the cells. In contrast, in differentiated preadipocytes, castration reduced Fos protein induction by almost half (-40 ± 10%, P < 0.05) in epididymal cells, an alteration which was partly restored by in vivo testosterone treatment. In differentiated preadipocytes from the other anatomical origins, however, androgenic status failed to apparently affect Fos induction.



View larger version (43K):
[in this window]
[in a new window]
 
Figure 4. Influence of androgenic status on Fos protein expression in confluent and differentiated preadipocytes from femoral sc, epididymal, and perirenal fat depots. Confluent and differentiated preadipocytes from SHAM (A, D, and G), CAST (B, E, and H) and CAST + T (C, F, and I) rats were treated by 10% serum for 90 min. Cell extracts were prepared and probed with anti-Fos antibody. A, Representative Western blot analysis of Fos protein. B, Densitometric analysis of Fos Western blots. The data are the means ± SEM obtained from five separate experiments and are expressed as percentage of control values (100% is assigned to each type of preadipocytes from SHAM rats). *, P < 0.05. Prestained molecular weight markers shown are 57 kDa and 39.5 kDa.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We have previously reported that castration induces both an increase in the proliferation capacity and an inhibition of the differentiation process in preadipocytes from the epididymal fat depots (7). The present study extends these observations by showing that castration actually increases adipose conversion of preadipocytes from perirenal fat depots.

The important fact that castration can influence in two opposite ways the adipogenic process in deep intraabdominal preadipocytes depending on their anatomical origin is presently unexplained. However, this demonstrates that precursor fat cells from deep intraabdominal fat depots are not comparable at least in terms of the reactivity of their adipogenic capacities to androgenic status. Perirenal fat depots contain more differentiating preadipocytes than other depots (4, 5). Moreover, neither an activator of adipogenesis like 2-bromopalmitate (18) nor an antiadipogenic factor like TNF{alpha} (19) is able to influence adipose conversion of perirenal preadipocytes (Dieudonné MN et al., personal communication). These findings strongly suggest that perirenal preadipocytes are more highly committed in the in vivo/in vitro differentiation process than those from the epididymal site. The opposite effects of androgen deprivation on perirenal and epididymal preadipocyte adipose conversion could then be explained if, as described for glucocorticoids (20), one assumes that modulation of adipogenesis by androgens depends on a critical time of exposure.

To get more informations on the molecular mechanisms underlying the effects of androgenic status on adipogenesis of intraabdominal preadipocytes, we have studied some elements of the MAP kinase cascade/Fos signaling pathways which are involved in preadipocyte proliferation and differentiation (11, 21).

In control rats, our results suggest that the variability of the proliferative capacity as a function of the preadipocyte anatomical origin (4, 5) is not related to differences in the MAP kinase cascade. In fact, p42/p44 MAP kinase activities and immunoblot levels of two upstream activators, MEK and Raf-1, were found to be similar in preadipocytes isolated from the three different fat depots studied.

The proliferative effect of castration specifically seen in perirenal and epididymal preadipocytes, is associated with high MAP kinase activity. It should be noted, however, that increased MEK and Raf-1 protein expression after castration were observed only in epididymal cells. The reasons explaining these site-related specificities remain to be established.

In various cell types, MAP kinase activation in response to growth factors has been found to induce rapid c-fos expression (10). As presently shown, however, the high MAP kinase activity observed in proliferating preadipocytes from epididymal and perirenal fat depots was not accompanied by a high Fos protein induction. It cannot be excluded that in these cells, like in Rat-1 fibroblasts (22), the pathways linking MAP kinase to c-fos induction are uncoupled.

On the other hand, MAP kinase is positively regulated by cAMP in preadipose cell lines (23) and in rat preadipocytes (unpublished results). However, castration was shown by us to induce defective cAMP production in rat epididymal preadipocytes (24). Therefore, the high MAP kinase activity found in epididymal preadipocytes is probably more the consequence of increased function of the tyrosine kinase/growth factor signaling pathways than of the cAMP-mediated one.

Several studies have demonstrated that high MAP kinase activity leads to increased transcription of proliferation related genes (for reviews, see Refs. 25, 26). One candidate gene could be c-myc, which plays a crucial role in preadipocyte mitogenesis (27) and whose expression is also induced after MAP kinase activation (28). Experiments are currently in progress to test this hypothesis.

In differentiated preadipocytes, MAP kinase activity was found 5- to 10-fold lower than in proliferating cells and was shown to be variable according to preadipocyte anatomical origin. The lowest MAP kinase activity was observed in perirenal cells which have a high differentiation capacity (4–5, 29, this study).

MAP kinase activity in differentiated preadipocytes was insensitive to the androgenic status whatever the anatomical origin of these cells. This could be explained by the finding that this activity sharply decreased during adipogenesis, and also by the observation, that MAP kinase is predominantly involved in the control of the proliferation and less in the differentiation process of 3T3-L1 preadipocytes (30).

Proto-oncogene c-fos has been shown to play a pivotal role in preadipocyte proliferation by promoting the expression of adipo-specific genes such as the lipid binding protein aP2 (11). Therefore, the decreased Fos protein induction seen in epididymal cells after castration could explain, at least in part, how castration induces a defective adipogenesis in these cells. In contrast, the high differentiation capacity elicited by perirenal cells was not correlated with variations of Fos protein induction. Besides c-fos, other transcriptional factors are deeply implied in the control of adipogenesis. Among these factors, C/EBP{alpha}, which is highly expressed in adipose tissue, is important because its expression is necessary and sufficient for adipocyte differentiation commitment (31). That castration could influence the expression of C/EBP{alpha} in preadipocytes seems all the more likely as preliminary experiments from our laboratory reveal that C/EBP{alpha} expression is differently affected by castration in epididymal and perirenal preadipocytes as well.

Finally, few studies have been devoted to androgen regulation of nuclear proto-oncogene transcription (32). It is thus difficult to establish whether the alterations caused by castration on the MAP kinase/c-fos signaling pathways are due or not to androgen deficiency. The question of a direct effect of testosterone on preadipocytes remains open. Androgen receptor number exhibits variations according to the anatomical origin of rat preadipocytes (2, 3). This number is decreased in castrated rats and is up-regulated both in vitro (2, 3) and in vivo (Dieudonné et al., unpublished results) by testosterone. The fact that, in vivo, testosterone treatment did not correct some of the alterations induced by castration (growth rate and MAP kinase activity) indicates that these alterations cannot be fully accounted for testosterone deficiency. These observations rather suggest that lack of some products of the testis other than testosterone (steroidal and non steroidal testicular factors) could play a significant role in these effects of castration. Additional in vitro experiments will be required to test this hypothesis.

In conclusion, this study shows that androgenic status influences site-specifically the proliferation and differentiation capacities of the deep intraabdominal preadipocytes. These influences appear to be at least in part related to alterations of some components of the signaling pathways controlling adipogenesis. Abdominal fat mass development being inversely correlated with blood testosterone levels in man (1), this report showing hyperplasia (increased proliferation and differentiation) of perirenal preadipocytes after castration could provide additional information on the regulation of deep intraabdominal fat mass deposition by sex hormones.


    Footnotes
 
1 This work was supported by the INSERM (CJF 94–02), the Université of Paris V, and the Comité des Yvelines de la Ligue contre le Cancer. Back

Received October 21, 1996.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Bjorntorp P 1991 Metabolic implications of body fat distribution. Diabetes Care 14:1132–1143[Abstract]
  2. De Pergola G, Xu X, Yang S, Giorgino R, Bjorntorp P 1990 Up-regulation of androgen receptor binding in male rat fat pad adipose precursor cells exposed to testosterone: study in a whole assay system. J Steroid Biochem Mol Biol 37:553–558[CrossRef][Medline]
  3. Dieudonne MN, Pecquery R, Leneveu MC, Jaubert AM, Giudicelli Y 1995 Androgen receptor in cultured rat adipose precursor cells during proliferation and differentiation: regional specificities and regulation by testosterone. Endocrine 3:537–541[CrossRef]
  4. Djian P, Roncari DAK, Hollenberg CH 1983 Influence of anatomic site and age on the replication and differentiation of rat adipose precursors in culture. J Clin Invest 72:1200–1208
  5. Lau DCW, Wang KL, Tough SC 1987 Regional differences in the replication rate of cultured rat microvascular endothelium from retroperitoneal and epididymal fat pads. Clin Exp Metab 36:631–636
  6. Kirkland JL, Hollenberg CH, Gillon W, Kindler S 1992 Effect of hypophysectomy on rat preadipocyte replication and differentiation. Endocrinology 131:2769–2773.[Abstract/Free Full Text]
  7. Lacasa D, Agli B, Moynard D, Giudicelli Y 1995 Evidence for a regional-specific control of rat preadipocyte proliferation and differentiation by the androgenic status. Endocrine 3:789–793[CrossRef]
  8. Lenormand P, Pages G, Sardet C, L’Allemain G, Meloche S, Pouyssegur J 1993 MAP kinases: activation, subcellular localization and role in the control of cell proliferation. In: Brown BL, Dobson PRM (eds) Advances in Second Messenger and Phosphoprotein Research, vol 28, Raven Press, Ltd., New York, pp 237–244
  9. Campbell JS, Seger R, Graves JD, Graves LM, Jensen AM, Krebs EG 1995 The MAP kinase cascade. Recent Prog Horm Res 50:131–159
  10. Janknecht R, Cahill MA, Nordheim A 1995 Signal integration at the c-fos promoter. Carcinogenesis 16:443–450[Free Full Text]
  11. Spiegelman BM, Distel RJ, Ro HS, Rosen BS, Satterberg B 1988 Fos protooncogene and the regulation of gene expression in adipocyte differentiation. J Cell Biol 107:829–832[Free Full Text]
  12. Lacasa D, Agli B, Mur M, Dieudonne MN, Giudicelli Y 1993 Protein kinase C in rat adipocytes: influence of androgenic status and regional fat distribution. J Endocrinol 138:493–501[Abstract/Free Full Text]
  13. Deslex J, Negrel R, Ailhaud G 1987 Development of a chemically defined serum-free medium for differentiation of rat adipose precursor cells. Exp Cell Res 168:15–30[CrossRef][Medline]
  14. Alessi DR, Cohen P, Aswoth A, Cowley S, Leevers SJ, Marshall CJ 1995 Assay and expression of mitogen-activated protein kinase, MAP kinase kinase and Raf. Methods Enzymol 255:279–290[Medline]
  15. Wise S, Green H 1979 Participation of one isoenzyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 cells. J Biol Chem 254:273–275[Abstract/Free Full Text]
  16. Morrison DK 1995 Mechanisms regulating Raf-1 activity in signal transduction pathways. Mol Reprod Dev 42:507–514[CrossRef][Medline]
  17. Berra E, Diaz-Meco MT, Lozano J, Frutos S, Municio MM, Sanchez P, Sanz L, Moscat J 1996 Evidence for a role of MEK and MAPK during signal trandsduction by protein kinase C zeta. EMBO J 14:6157–6163[Medline]
  18. Amri EZ, Ailhaud G, Grimaldi PA 1994 Fatty acids as signal transduction molecules: involvement in the differentiation of preadipose to adipose cells. J Lipid Res 35:930–937[Abstract]
  19. Ninomyia-Tsuji J, Torti FM, Ringold GM 1993 Tumor necrosis factor-induced c-myc expression in the absence of mitogenesis is associated with inhibition of adipocyte differentiation. Proc Natl Acad Sci USA 90:9611–9615[Abstract/Free Full Text]
  20. Xu X, Bjorntorp P 1990 Effect of dexamethasone on multiplication and differentiation of rat adipose precursor cells. Exp Cell Res 189:247–252[CrossRef][Medline]
  21. Sale EM, Atkinson PGP, Sale GJ 1996 Requirement of MAP kinase for differentiation of fibroblasts to adipocytes for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. EMBO J 14:674–684[Medline]
  22. Wyke AW, Lang A, Frame MC 1996 Uncoupling of the pathways which link MAP kinase to c-fos transcription and AP-1 in response to growth factors. Cell Signal 2:131–139
  23. Yarwood SJ, Kilgour E, Anderson NG 1996 Cyclic AMP stimulates the phosphorylation and activation of p42 and p44 mitogen-activated protein kinase in 3T3–F44 2A preadipocytes. Biochem Biophys Res Commun 224:734–739[CrossRef][Medline]
  24. Lacasa D, Denis-Henriot D, Agli B, De Mazancourt P, Giudicelli Y 1994 Rat preadipocyte adenylyl cyclase: influence of fat localization and androgenic status. Biochim Biophys Acta 1224:527–532[Medline]
  25. Davis RJ 1993 The mitogen-activated protein kinase signal transduction pathways. J Biol Chem 268:14553–14555[Free Full Text]
  26. Karin M 1996 The regulation of AP-1 activity by mitogen-activated protein kinases. Phil Trans R Soc Lond 351:127–134[Medline]
  27. Freytag SO, Geddes TJ 1992 Reciprocal regulation of adipogenesis by Myc and C/EBP{alpha}. Science 256:379–382[Abstract/Free Full Text]
  28. Gupta S, Seth A, Davis RJ 1993 Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites of THR 58 and SER 62. Proc Natl Acad Sci USA 90:3216–3220[Abstract/Free Full Text]
  29. Kirkland JL, Hollenberg CH, Gillon WS 1996 Effect of fat depot site on differentiation-dependent gene expression in rat preadipocytes. Int J Obesity 20:S102–S107
  30. Porras A, Muszynski K, Rapp VR, Santos E 1994 Dissociation between activating Raf-1 kinase and the 42-kDa mitogen-activated protein kinase/90-kDa S6 kinase (MAPK/RSK) cascade in the insulin/Ras pathway of adipocytic differentiation of 3T3–L1 cells. J Biol Chem 269:12741–12748[Abstract/Free Full Text]
  31. McDouglas OA, Lane MD 1995 Transcription regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 64:345–373[CrossRef][Medline]
  32. Schuchard M, Landers JP, Punkay Sandhu N, Spelsberg TC 1993 Steroid hormone regulation of nuclear proto-oncogenes. Endocr Rev 14:659–669[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
EndocrinologyHome page
V. K. Khor, M. H. Tong, Y. Qian, and W.-C. Song
Gender-Specific Expression and Mechanism of Regulation of Estrogen Sulfotransferase in Adipose Tissues of the Mouse
Endocrinology, November 1, 2008; 149(11): 5440 - 5448.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
E. Dos Santos, M.-N. Dieudonne, M.-C. Leneveu, R. Pecquery, V. Serazin, and Y. Giudicelli
In vitro effects of chorionic gonadotropin hormone on human adipose development
J. Endocrinol., August 1, 2007; 194(2): 313 - 325.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. Serazin-Leroy, M. Morot, P. de Mazancourt, and Y. Giudicelli
Androgen regulation and site specificity of angiotensinogen gene expression and secretion in rat adipocytes
Am J Physiol Endocrinol Metab, December 1, 2000; 279(6): E1398 - E1405.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
D. Deplewski and R. L. Rosenfield
Role of Hormones in Pilosebaceous Unit Development
Endocr. Rev., August 1, 2000; 21(4): 363 - 392.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. M. GREGOIRE, C. M. SMAS, and H. S. SUL
Understanding Adipocyte Differentiation
Physiol Rev, July 1, 1998; 78(3): 783 - 809.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. N. Dieudonne, R. Pecquery, A. Boumediene, M. C. Leneveu, and Y. Giudicelli
Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids
Am J Physiol Cell Physiol, June 1, 1998; 274(6): C1645 - C1652.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. M. Boney, R. M. Smith, and P. A. Gruppuso
Modulation of Insulin-Like Growth Factor I Mitogenic Signaling in 3T3-L1 Preadipocyte Differentiation
Endocrinology, April 1, 1998; 139(4): 1638 - 1644.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lacasa, D.
Right arrow Articles by Giudicelli, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lacasa, D.
Right arrow Articles by Giudicelli, Y.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals